The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

被引：0
|
作者：
Jingjia Cao
Xiaolu Zhu
Yaru Sun
Xiao Li
Canhua Yun
Wei Zhang
机构：
[1] the Second Hospital,Department of Nuclear Medicine
[2] Cheeloo College of Medicine,undefined
[3] Shandong University,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2022年 / 49卷
关键词：
BRAF V600E; TERT promoter mutation; Radioiodine therapy; Papillary thyroid carcinoma; Therapy response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3470 / 3481
页数：11
相关论文
共 50 条
  • [1] The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
    Cao, Jingjia
    Zhu, Xiaolu
    Sun, Yaru
    Li, Xiao
    Yun, Canhua
    Zhang, Wei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3470 - 3481
  • [2] The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
    Liu, Jiajun
    Liu, Rengyun
    Shen, Xiaopei
    Zhu, Guangwu
    Li, Biao
    Xing, Mingzhao
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 177 - 182
  • [3] Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality
    Liu, Rengyun
    Bishop, Justin
    Zhu, Guangwu
    Zhang, Tao
    Ladenson, Paul W.
    Xing, Mingzhao
    JAMA ONCOLOGY, 2017, 3 (02) : 202 - 208
  • [4] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
    Ge, Junshang
    Wang, Jie
    Wang, Hui
    Jiang, Xianjie
    Liao, Qianjin
    Gong, Qian
    Mo, Yongzhen
    Li, Xiaoling
    Li, Guiyuan
    Xiong, Wei
    Zhao, Jin
    Zeng, Zhaoyang
    JOURNAL OF CANCER, 2020, 11 (04): : 932 - 939
  • [5] BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
    Sun, Jian
    Zhang, Jing
    Lu, Junliang
    Gao, Jie
    Ren, Xinyu
    Teng, Lianghong
    Duan, Huanli
    Lin, Yansong
    Li, Xiaoyi
    Zhang, Bo
    Liang, Zhiyong
    PLOS ONE, 2016, 11 (04):
  • [6] TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
    Kim, Min Jhi
    Kim, Jin Kyong
    Kim, Gi Jeong
    Kang, Sang-Wook
    Lee, Jandee
    Jeong, Jong Ju
    Chung, Woong Youn
    Kim, Daham
    Nam, Kee-Hyun
    CANCERS, 2022, 14 (19)
  • [7] BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
    Xing, Mingzhao
    Liu, Rengyun
    Liu, Xiaoli
    Murugan, Avaniyapuram Kannan
    Zhu, Guangwu
    Zeiger, Martha A.
    Pai, Sara
    Bishop, Justin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2718 - +
  • [8] BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
    Groener, Jan Benedikt
    Gelen, Debora
    Mogler, Carolin
    Herpel, Esther
    Toth, Csaba
    Kender, Zoltan
    Peichl, Marco
    Haufe, Sabine
    Haberkorn, Uwe
    Sulaj, Alba
    Zemva, Johanna
    Kopf, Stefan
    Nawroth, Peter Paul
    Brune, Maik
    Rudofsky, Gottfried
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 69 - 75
  • [9] Quantitation of BRAF V600E alleles predicts papillary thyroid cancer progression
    Jung, Chan Kwon
    Kim, Min Hee
    Bae, Ja Seong
    Lim, Dong Jun
    Lee, Hyoungnam
    Jeon, So Ra
    Park, Gyeong Sin
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression
    Kim, Min-Hee
    Bae, Ja Seong
    Lim, Dong-Jun
    Lee, Hyoungnam
    Jeon, So Ra
    Park, Gyeong Sin
    Jung, Chan Kwon
    ENDOCRINE-RELATED CANCER, 2014, 21 (06) : 891 - 902
12345